About: Sibrotuzumab

An Entity of Type: monoclonal antibody, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

Sibrotuzumab is a humanized monoclonal antibody intended for the treatment of cancer. It binds to FAP In 2003 it failed a phase II clinical trial for metastatic colorectal cancer.

Property	Value
dbo:abstract	Sibrotuzumab is a humanized monoclonal antibody intended for the treatment of cancer. It binds to FAP In 2003 it failed a phase II clinical trial for metastatic colorectal cancer. (en) Il sibrotuzumab è un anticorpo monoclonale umanizzato ricombinante studiato per il trattamento di forme di tumore. Si lega ed agisce sulla proteina attivatore del fibroblata FAP. (it)
dbo:casNumber	216669-97-5
dbo:fdaUniiCode	552U6E1NIW
dbo:wikiPageID	9685939 (xsd:integer)
dbo:wikiPageLength	2824 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID	1003464281 (xsd:integer)
dbo:wikiPageWikiLink	dbr:Colorectal_cancer dbc:Monoclonal_antibodies_for_tumors dbr:Fibroblast_activation_protein,_alpha dbr:Humanized_monoclonal_antibody dbr:Fibroblast_activation_protein
dbp:atcPrefix	none (en)
dbp:casNumber	216669 (xsd:integer)
dbp:chemspiderid	none (en)
dbp:mabType	mab (en)
dbp:source	zu/o (en)
dbp:target	dbr:Fibroblast_activation_protein
dbp:type	mab (en)
dbp:unii	552 (xsd:integer)
dbp:verifiedfields	changed (en)
dbp:verifiedrevid	464389928 (xsd:integer)
dbp:wikiPageUsesTemplate	dbt:Antineoplastic-drug-stub dbt:Drugbox dbt:Reflist dbt:Cascite dbt:Chemspidercite dbt:Drugbankcite dbt:Fdacite dbt:Monoclonal-antibody-stub dbt:Monoclonals_for_tumors
dcterms:subject	dbc:Monoclonal_antibodies_for_tumors
gold:hypernym	dbr:Antibody
rdf:type	owl:Thing dul:ChemicalObject dbo:ChemicalSubstance wikidata:Q8386 dbo:MonoclonalAntibody yago:WikicatMonoclonalAntibodies yago:WikicatMonoclonalAntibodiesForTumors yago:Abstraction100002137 yago:Antibody115027189 yago:Chemical114806838 yago:Compound114818238 yago:Macromolecule114944888 yago:Material114580897 yago:Matter100020827 yago:Molecule114682133 yago:MonoclonalAntibody115029781 yago:OrganicCompound114727670 yago:Part113809207 yago:PhysicalEntity100001930 yago:Protein114728724 yago:Relation100031921 dbo:Drug yago:Substance100019613 yago:Thing100002452 yago:Unit109465459
rdfs:comment	Sibrotuzumab is a humanized monoclonal antibody intended for the treatment of cancer. It binds to FAP In 2003 it failed a phase II clinical trial for metastatic colorectal cancer. (en) Il sibrotuzumab è un anticorpo monoclonale umanizzato ricombinante studiato per il trattamento di forme di tumore. Si lega ed agisce sulla proteina attivatore del fibroblata FAP. (it)
rdfs:label	Sibrotuzumab (it) Sibrotuzumab (en)
owl:sameAs	freebase:Sibrotuzumab wikidata:Sibrotuzumab dbpedia-it:Sibrotuzumab https://global.dbpedia.org/id/3f9fE yago-res:Sibrotuzumab
prov:wasDerivedFrom	wikipedia-en:Sibrotuzumab?oldid=1003464281&ns=0
foaf:isPrimaryTopicOf	wikipedia-en:Sibrotuzumab
is dbo:wikiPageWikiLink of	dbr:Fibroblast_activation_protein,_alpha dbr:List_of_therapeutic_monoclonal_antibodies dbr:List_of_drugs:_Si
is foaf:primaryTopic of	wikipedia-en:Sibrotuzumab